FindTrial
Sign In

Effective dose of dexmedetomidine in uriniary incontinence surgery: a pilot study

Optimal continuous infusion dose of dexmedetomidine for monitored anesthetic care in patients receiving trausobturator sling operation

Status
Unknown
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000824
Enrollment
90
Registered
2013-08-20
Start date
2013-08-27
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients receiving TOT sling operation due to urinary incontinence in the department of urology of Asan Medical Center

Exclusion criteria

Exclusion criteria: 1. Patients who want to receive general anesthesia or regional anesthesia 2. Patients who have cerebrovascular disease or coronary artery disease 3. Patients who have medication or pacemaker inserion for clinically significant arrhythmia 4. Patients of preoperative bradycardia (Heart Rate < 50 bpm) or systolic blood pressure < 90 mmHg 5. patients who have significant liver or renal disease 6. Patients who have neurological or neurosurgical disease

Design outcomes

Primary

MeasureTime frame
total rescue dose of intravenous fentanyl;total rescue dose of intravenous midazolam—

Secondary

MeasureTime frame
blood pressure;heart rate;Bisprectral Index—

Countries

Korea, Republic of

Contacts

Public ContactHyungseok Seo

Asan Medical Center

seohyungseok@gmail.com+82-2-3010-5683

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026